Volcano Corporation Announces Agreement To Acquire Crux Biomedical For $36.0M

Volcano Corporation (Nasdaq: VOLC ), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has signed an agreement to acquire Crux Biomedical, a privately-held company that has developed a highly differentiated inferior